Processa Pharmaceuticals PCSA Q4 2025 Earnings EPS Misses Estimates by a Wide Margin as PreRevenue Biotech Advances Pipeline Manchester United Q1 2026 Earnings Strong EPS Surprise Amid Revenue Disparities JBI Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Absence PAHC Q1 2026 Earnings EPS Surpasses Expectations Amid Operational Strength CIG Q1 2026 Earnings EPS Beats Estimates by 1247 Shares Edge Lower Northwest Bancshares Q1 2026 Earnings EPS Surges Past Consensus as Expense Discipline Supports Results